LoginCreate an account

  Username: Password:
 
Home

Merck, Schering-Plough in $42M Vytorin settlement

E-mail Print PDF
User Rating: / 0
PoorBest 

NEW YORK (AP) — Drug developers Merck & Co. and Schering-Plough Corp. said Wednesday they will pay $41.5 million to settle a series of lawsuits claiming they delayed key study results on their cholesterol drug Vytorin because the data was unfavorable.

In January 2008, the companies released long-awaited study data showing Vytorin and Zetia were no more effective than Zocor, an older and less expensive cholesterol treatment at reducing plaque buildup in arteries. Zocor is combined with Zetia to make Vytorin.

The companies finished testing Vytorin in 2006 and the drug was given Food and Drug Administration approval based on its ability to lower cholesterol. Merck and Schering-Plough were criticized for not releasing the data earlier. Following the study results, sales of Vytorin sunk.

During the second quarter of 2009, combined sales of Vytorin and Zetia fell 10 percent to $1 billion.

Merck and Schering-Plough did not acknowledge any wrongdoing or liability as part of the settlement, which comes a month after a separate $5.4 million settlement with attorneys general from 35 states and the District of Columbia.

Whitehouse Station, N.J.-based Merck is in the midst of a $41.1 billion buyout of Schering-Plough.

"These agreements will allow the companies to avoid continuing defense costs and remain focused on discovering, developing and delivering novel medicines and vaccines," said Bruce N. Kuhlik, executive vice president and general counsel at Merck.

The company previously disclosed more than 140 lawsuits pending in federal court in New Jersey. The deal actually involves two settlements split with consumers and health plans. The consumer settlements still require court approval.

Charges for the settlement were included in the companies' second-quarter results for the cholesterol drug joint venture.

 

Copyright 2009 The Associated Press.

 

 
The Axe Files with David Axelrod
David Axelrod, the founder and director of the University of Chicago Institute of Politics, brings you The Axe Files, a series of revealing interviews with key figures in the political world. Go beyond the soundbites and get to know some of the most interesting players in politics.
  • Ep. 47 - Frank Bruni
    Frank Bruni, author and columnist for the New York Times, chats with David about his long and diverse career in journalism from New York to Detroit to Rome, Donald Trump's odds of winning the general election, gay marriage, and more.
  • Ep. 46 - Patrick Kennedy
    Patrick Kennedy, former Democratic congressman from Rhode Island and son of the late Sen. Ted Kennedy, chats with David about growing up in the Kennedy family, his battle with mental illness and addiction, his new book “The Common Struggle” and more.

  • Ep. 45 - Arthur Brooks
    Arthur Brooks, president of the American Enterprise Institute and author of “The Conservative Heart,” chats with David about his time living in Europe, the U.S. Immigration debate, how to combat the current political polarization, and more.
FOX News
FOXNews.com - Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
FOX News

Search...

WebSite

mySSnews Login



User Menu